涎腺内翻性导管乳头状瘤1例

患者男性,64岁,无意中发现左颊部肿物,无自觉症状.查体:肿物位于左颊黏膜,大小约0.5cm×0.2cm,有红、肿表现,其下有蒂,表面似有破溃,手术切除肿块送病理检查.病理检查 灰白色、灰粉色黏膜组织一块,大小1.5 cm×1 cm×0.6 cm,表面大部分光滑,局部呈小乳头状,切面灰粉色,质韧.镜检:肿瘤组织与黏膜相延续,大部分区域呈内生性生长,局部呈乳头状外生性生长(图1),肿瘤实质主要为基底细胞样鳞状细胞呈乳头状增生,乳头表面为柱状上皮,可见微囊、囊及黏液细胞(图2),上皮细胞异型性不明显,未见核分裂象.免疫表型:肿瘤细胞及周围正常小导管表达CK19;除柱状上皮外肿瘤细胞及正常小导管均表达CKHW(34βE12)(图3);柱状上皮细胞高表达EMA,肿瘤细胞中度表达(图4).     

支气管涎腺乳头状瘤4例临床病理及基因特征分析

目的:探讨支气管涎腺乳头状瘤（bronchial sialadenoma papilliferum,BSP）的临床及组织病理学特征、免疫组织化学表型及基因特征。方法:通过回顾性阅片筛选,收集同济大学附属上海市肺科医院2018年5月至2021年6月诊断的4例BSP,观察其临床及组织病理学、免疫组织化学及分子病理特点,随访...     

人乳头状瘤病毒16、18型变异及相关肿瘤

肿瘤的形成可由多种病毒引起[1],其一就是人类乳头状瘤病毒(Human papillomavirus,HPV).HPV是1949年从普通疣体浸出液中首次被观察到,1995年有研究证实HPV感染为宫颈癌的致病病原体.研究显示:HPV16、18能促使人类鳞状上皮的增生.目前HPV16、18变异体的致瘤性受到各国学者的广泛关注.     

女性下生殖道癌临床病理特征与人乳头状瘤病毒型别间的相关性研究

目的：探讨女性下生殖道癌的临床病理与人乳头状瘤病毒（HPV）型别之间的关系。方法：回顾性研究100例下生殖道癌（宫颈癌63例,外阴癌37例）的临床病理特征,并应用PCR技术检测每份标本的HPV状态。结果：在模板内参照阳性的87份中,宫颈癌54份,外阴癌33份,HPV阳性率在宫颈癌中为88．3％,以HPV16型（55．6％）和HPV18型（24．4％）为主,在33例外阴鳞癌中,HPV阳性仅见于基底细胞癌和混疣样癌,阳性率均为83．3％,以HPV16型为主（70．0％）;6例基底细胞样癌中有3例合并宫颈鳞状上皮肿瘤,其中2例宫颈与外阴的肿瘤均为HPV16型阳性;21例角化鳞癌则未检测出HPV－DNA,但有发病年龄高（平均63．3岁）。形态学上角化明显和预后较差等特征。结论：HPV16型和18型在宫颈癌中性阳率较高,而在外阴癌中HPV阳性的意义则因组织学类型而不相同。     

人乳头状瘤病毒DNA疫苗

人乳头瘤病毒 (HPV) ,尤其是HPV1 6型 ,是子宫颈癌的主要病原体。因此 ,通过引起病人适当的病毒特异性免疫反应可以预防或治疗HPV相关的子宫颈恶性肿瘤。在已经进行预防接种的个体中 ,包括L1和L2在内的HPV衣壳蛋白已经显示出能够产生对抗HPV颗粒抗体的抑制。此外 ,HPV致瘤性蛋白 ,例如E6蛋白和E7蛋白 ,在细胞转换的导入和维持方面是很重要的 ,在大多数包含HPV的癌症中它们也是共同表达的。它们为产生抗HPV感染和HPV相关肿瘤形成的治疗量的疫苗提供了理想的靶。针对这些蛋白的疫苗可能提供一个控制HPV相关恶性肿瘤的机会。拥有…     

人乳头状瘤病毒感染及其亚型与鼻内翻性乳头状瘤相关性探讨

目的 了解不同亚型的人乳头状瘤病毒(human papillomavirus,HPV)在鼻内翻性乳头状瘤(nasal inverted papilloma,NIP)中的分布,探讨其在NIP发病中的作用.方法 将78例NIP腊包埋组织标本分为单纯NIP组、伴不典型增生NIP组和NIP癌变组,同时选取40例健康体检者鼻腔粘膜组织作为健康对照组,采用聚合酶链反应(PCR)技术检测HPV6、11、16及18型感染情况.结果 78例NIP石蜡包埋组织标本HPV总阳性率为61.5％.单纯NIP组、伴不典型增生NIP组和NIP癌变组阳性率分别达59.5％、73.9％和46.2％.随着NIP临床分期级别的升高,HPV感染率也呈相应的上升趋势.单纯NIP组以低危型HPV6、11型感染为主,NIP癌变组则同时检出高危型HPV16型和HPV18型.结论 HPV感染在NIP发病中起着重要作用,其中高危型HPV感染能扩大NIP病变范围,而HPV16、18型可能与NIP恶变有关联.     

人乳头状瘤病毒不同型别与宫颈病变的相关性研究

目的探讨人乳头状瘤病毒（ＨＰＶ）不同型别与宫颈病变性质的关系。方法应用ＰＣＲ技术和原位杂交方法对６１例宫颈上皮内瘤（ＣｅｒｖｉｃａｌｉｎｔｒａｅｐｉｔｈｅｌｉａｌＮｅｏｐｌａｓｉａＣＩＮ）和１２例宫颈鳞癌（ＳＣＣ）进行ＨＰＶ６Ｂ／１１、１６、１８ＤＮＡ检测。结果ＰＣＲ检测结果显示ＨＰＶ６、１１主要分布于低度鳞状上皮内病变（６１９％）和一部分ＣＩＮⅡ中（２０％），而在ＣＩＮⅢ和ＳＣＣ中检测不到；ＨＰＶ１６、１８的检出率随ＣＩＮ级别增高而增加，在ＳＣＣ中高达８３３％。原位杂交结果显示在低度鳞状上皮内病变中，地高辛（Ｄｉｇ）标记的ＨＰＶ６Ｂ／１１、１６、１８ＤＮＡ杂交物质在核中均呈细颗粒状，为“游离型”。上述杂交阳性信号形态亦出现于ＣＩＮⅡ的所有ＨＰＶ６Ｂ／１１及部分ＨＰＶ１６、１８型感染中，而ＣＩＮⅢ和宫颈鳞癌及部分ＣＩＮⅡ中，其杂交阳性信号均为非颗粒状的“整合型”。结论低度鳞状上皮内病变是以ＨＰＶ６、１１低危型为主的多型别病毒的繁殖性感染，ＣＩＮⅢ和宫颈鳞癌为ＨＰＶ１６、１８高危型病毒的整合型感染，而在ＣＩＮⅡ中存在着ＨＰＶ６，１１和ＨＰＶ１６，１８的繁殖性感染及ＨＰＶ１６，１８的整合型感染     

人乳头状瘤病毒感染及感染拷贝数与食管癌的关系

人乳头状瘤病毒感染及感染拷贝数与食管癌的关系吕丽春沈忠英游绍进沈健蔡唯佳一、材料和方法收集１９９４年～１９９５年我院附属医院外科手术切除、病理确诊的新鲜食管癌标本５５例，每例分别取癌组织、癌旁粘膜和远端切缘粘膜３部分，经ＯＣＴ包埋在一起，常规冰冻切片...     

人乳头状瘤病毒DNA疫苗

人乳头瘤病毒(HPV)，尤其是HPVl6型，是子宫颈癌的主要病原体。因此，通过引起病人适当的病毒特异性免疫反应可以预防或治疗HPV相关的子宫颈恶性肿瘤。在已经进行预防接种的个体中．包括L1和L2在内的HPV衣壳蛋白已经显示出能够产生对抗HPV颗粒抗体的抑制。此外，HPV致     

涎腺皮脂腺淋巴腺瘤1例

患者女 ,2 7岁 ,因右颌下包块 4个月余入院。发病初肿块如花生米大小 ,无不适感 ,呈渐进性增大 ,现如鹌鹑蛋大小 ,质软 ,无触痛。Ｂ超示颌下腺囊腺瘤。手术所见 :右侧颌下腺区域见一个约 3ｃｍ× 3ｃｍ× 2ｃｍ大小的包块 ,有完整包膜 ,与颌下腺相连。临床诊断 :右侧颌下腺囊腺瘤。　　病理检查　眼观 :椭圆形结节一个 ,5ｃｍ× 3ｃｍ× 2ｃｍ ,质软 ,表面灰红灰白色 ,包膜完整 ;切面呈囊实性 ,囊腔约0 5～ 1ｃｍ ,部分内含灰黄色凝固性皮脂 ,未见毛发 ,部分内含灰黄色浑浊液体 ,实质区域灰红色。膜外见正常腺体残留 ,约 1 5ｃｍ× 1ｃｍ×…     

Communicating about HPV in the context of head and neck cancer: A systematic review of quantitative studies

ObjectiveRising incidence of HPV-positive head and neck cancers (HPV-HNC) means HPVinfection is increasingly relevant to patient-provider consultations. We performed a systematic review to examine, in the context of patient-provider HNC consultations: discussions about HPV, attitudes towards discussing HPV and information needs.MethodsWe searched Embase, PsychINFO, and CINAHL + for studies to August 2018. Eligible studies included: HNC healthcare professionals (HCPs) and/or HNC patients investigated HNC patient-provider communication about HPV.ResultsTen studies were identified: six including HCPs and four including HNC patients. HCPs varied in confidence in HPV discussions, which was related to their HPV knowledge. Both HCPs and patients acknowledged the need for reliable HPV information. Factors which facilitated HPV discussions included accessible HPV information for patients and HCPs and good HPV knowledge among HCPs. Barriers included the perception, among HCPs, that HPV was a challenging topic to discuss with patients.ConclusionsInformation deficits, communication challenges and barriers to discussing HPV were identified in HNC patient-provider consultations.Practice implicationsAppropriate HPV information is needed for HCPs and patients. Professional development initiatives which increase HCPs’ HPV knowledge and build their communication skills would be valuable.     

Immunohistochemical localization of WT1 in epithelial salivary tumors

The subcellular localization of WT1 is controversial and has received little attention in the epithelial tumors of salivary glands. Paraffin-embedded, surgical specimens from 80 salivary tumors were investigated by immunohistochemistry using a monoclonal, anti-WT1 antibody (6F-H2, Dako). Immunostaining was seen in 14/14 pleomorphic adenomas (PAs), 6/6 myoepitheliomas, 4/4 basal cell adenomas, 4/4 canalicular adenomas, 0/7 Warthin tumors, 0/1 oncocytoma, 1/6 acinic cell carcinomas (Cas), 0/11 mucoepidemoid Cas, 1/11 adenoid cystic Cas, 11/12 polymorphous low-grade adenocarcinomas (PLGAs), 1/2 Ca ex PA, 0/1 salivary duct Ca and 0/1 clear cell adenocarcinoma. Stained-cell subpopulations up to 90% were not uncommon in the benign tumors. Up to 80% of cells in PLGA could be stained. Staining was weak to intense and confined to the cytoplasm of preferentially non-luminal or adjacent to stroma cells. One adenoid cystic Ca showed nuclear staining. The results suggest that WT1 is often highly expressed in benign non-oncocytic salivary tumors whereas the malignant tumors show decreased expression, the exception being PLGA. The expression is usually cytoplasmic and associated with non-luminal cells. PLGA immunoreactivities could be useful in histological differential diagnosis.     

Immunohistochemical distribution of human epidermal growth factor in salivary gland tumours

Summary Immunohistochemical identification of human epidermal growth factor (hEGF) was carried out in a total of 152 cases of salivary gland tumours, consisting 107 pleomorphic adenomas and their variants, 13 adenolymphomas and 32 adenoid cystic carcinomas. A high percentage of pleomorphic adenomas revealed markedly positive hEGF staining of the luminal surface cells of tubuloductal structures and of modified or neoplastic myoepithelial cells. Clear cells of the tumour showed various reactivities from very slight to strong. Eosinophilic epithelial cells of adenolymphoma gave a positive reaction for hEGF in all the cases, whereas most adenoid cystic adenoma lacked hEGF staining; however some cases showed positive staining of the tumour cells. The immunohistochemical detection of hEGF in most salivary gland tumours suggests this factor to be a possible new marker of salivary glands tumours, and to have a biological role in tumour proliferation.     

The cytomorphologic spectrum of salivary gland type tumors in the lung and mediastinum: A report of 16 patients

In the lung and mediastinum, salivary gland type tumors (SGTTs) can occur as either primary tumors or metastases from tumors arising in the major or minor salivary glands. This study reviewed the cytology cases of SGTTs in the lung and mediastinum diagnosed over a six‐year period at our institution. The specimens included a total of 22 exfoliative or aspiration cytology specimens identified in 16 patients. Two of the cases were primary tumors: adenoid cystic carcinoma (ACC) of the trachea and mucoepidermoid carcinoma (MEC) of the thymus. The remaining 20 tumors were metastases from the parotid, submandibular gland, tongue, nasal cavity, or soft palate. Eight of the 16 patients (50%) had a diagnosis of ACC, four (25%) had salivary duct carcinomas, two (12.5%) had MECs, one (6.25%) was a basaloid tumor, and one (6.25%) was polymorphous low grade adenocarcinoma. In our series, these SGTTs were more commonly metastatic in the lung or mediastinum (87.5% of the patients), and the most common histological subtype was ACC, followed by SDC. This study also illustrates the cytomorphologic features and diagnostic pitfalls of these unusual SGTTs. Diagn. Cytopathol. 2012. © 2011 Wiley Periodicals, Inc.     

Localization of prostate-specific antigen-like immunoreactivity in human salivary gland and salivary gland tumors

Immunoreactivity of prostate-specific antigen (PSA), a kallikrein-like enzyme present in the seminal plasma, was demonstrated by indirect immunoperoxidase staining using a PSA antiserum in the apical cytoplasm along the luminal border of small-sized duct epithelial cells of the major salivary (parotid and submandibular) gland of both sexes (56/56, 100%). No PSA-like immunoreactivity was seen in large-sized duct epithelial cells and acinar cells. Minor salivary gland ducts were negative. When inflammatory and atrophic changes were observed, ductal expression of PSA-like immunoreactivity was decreased (12/37, 32%) and the site of intracellular localization often became diffusely cytoplasmic. The immunoreactivity was absorbed by human seminal plasma. Immunoreactivities of prostatic acid phosphatase and sex hormone receptors were undetectable in the salivary gland. Twenty-nine (34%) of 86 salivary gland tumors with ductal differentiation were immunoreactive for PSA mainly in the cytoplasm. A PSA monoclonal antibody ER-PR8 detected immunoreactivity in the prostate but not in the salivary glands or their tumors. Prostate-specific antigen-like immunoreactivity in small-sized (intercalated) duct epithelial cells of the major salivary gland and their tumors may be due to cross-reactivity of the antiserum with kallikrein-like substances.     

Expression of Bcl-2 and Survivin in uterine cervical carcinogenesis and correlation between the expression and infection of HPV_(16/18)

Carcinomaofthecervixisthesecondleading causeofdeathamongwomenworldwide.Each year,anestimated500000casesarenewlydiag nosed[1].Manystudiesshowedinfectionofhu manpapillomavirus(HPV)wasoneofthemost importantetiologicfactorsforcervicalcarcinoma[24].Morethan95%ofallcervicalcarcinomas havebeenfoundtobeassociatedwithHPV(ma inlytypes16and18)[5].Thestudiesinmolec ularoncologyrecentlyshowedthatitresultedin occurrenceanddevelopmentofcervicalcarcinomasthatcarcinogenicfactorsmadeproto oncogene activatean…     

Communication technologies to improve HPV vaccination initiation and completion: A systematic review

ObjectivesThis systematic review examines the effectiveness of communication technology interventions on HPV vaccination initiation and completion.MethodsA comprehensive search strategy was used to identify existing randomized controlled trials testing the impact of computer-, mobile- or internet-based interventions on receipt of any dose of the HPV vaccine. Twelve relevant studies were identified with a total of 38,945 participants.ResultsThe interventions were delivered using several different methods, including electronic health record (i.e. recall/reminder) prompts, text messaging, automated phone calls, interactive computer videos, and email. Vaccine initiation and completion was greater for technology-based studies relative to their control conditions.ConclusionThere is evidence that interventions utilizing communication technologies as their sole or primary mode for HPV vaccination intervention delivery may increase vaccination coverage.Practice implicationsCommunication technologies hold much promise for the future of HPV vaccination efforts, especially initiatives in practice-based settings.